Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03487952Unknown

Evaluation of Lung Nodule Detection With Artificial Intelligence Assisted Computed Tomography in North China

Role: collaborator

NCT03473860Unknown

the Change of CEM and the Prognosis of Coronary Artery Disease in Real Clinical Practice

Role: lead

NCT03389529Unknown

the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice

Role: lead

All 3 trials loaded